[1]郑速征,白红丽,单秋歌.重组人干扰素α-1b联合沙棘干乳剂治疗儿童病毒性腹泻疗效观察[J].新乡医学院学报,2022,39(1):076-80.[doi:10.7683/xxyxyxb.2022.01.016]
　ZHENG Suzheng,BAI Hongli,SHAN Qiuge.Effect of recombinant human interferon α-1b combined with Shaji Ganruji in the treatment of children with viral diarrhea[J].Journal of Xinxiang Medical University,2022,39(1):076-80.[doi:10.7683/xxyxyxb.2022.01.016]
点击复制

重组人干扰素α-1b联合沙棘干乳剂治疗儿童病毒性腹泻疗效观察
分享到：

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
39
期数:
2022年1
页码:
076-80
栏目:
临床研究
出版日期:
2022-01-05

文章信息/Info

Title:
Effect of recombinant human interferon α-1b combined with Shaji Ganruji in the treatment of children with viral diarrhea
作者:
郑速征; 白红丽; 单秋歌
（漯河医学高等专科学校第二附属医院儿科，河南　漯河　462000）
Author(s):
ZHENG Suzheng; BAI Hongli; SHAN Qiuge
(Department of Pediatrics,the Second Affiliated Hospital of Luohe Medical College,Luohe 462000,Henan Province,China)
关键词:
病毒性腹泻; 沙棘干乳剂; 重组人干扰素α-1b; 心肌酶谱
Keywords:
viral diarrheaShaji Ganrujirecombinant human interferon α-1bmyocardial zymogram
分类号:
R614
DOI:
10.7683/xxyxyxb.2022.01.016
文献标志码:
A
摘要:
目的　探讨重组人干扰素α-1b联合沙棘干乳剂治疗儿童病毒性腹泻的临床效果。方法　选择2017年3月至2019年2月漯河医学高等专科学校第二附属医院收治的88例病毒性腹泻患儿为研究对象，按照治疗方法将患儿分为观察组和对照组，每组44例。2组患儿均给予积极纠正酸中毒、静脉补液纠正脱水、无乳糖饮食、蒙脱石散、双歧杆菌四联活菌片等常规治疗措施，观察组患儿在常规治疗基础上给予重组人干扰素α-1b和沙棘干乳剂联合治疗。观察并比较2组患儿脱水纠正时间、腹泻停止时间、住院时间及不良反应；对2组患儿治疗前后血清肌酸激酶（CK）、乳酸脱氢酶（LDH）、天门冬氨酸氨基转移酶（AST）、α-羟丁酸脱氢酶（α-HBD）、肌酸激酶同工酶MB（CK-MB）、二胺氧化酶（DAO）水平及粪便钙卫蛋白（Fcp）水平、肠道菌群进行比较；治疗后判定2组患儿临床疗效。结果　观察组患儿脱水纠正时间、腹泻停止时间、住院时间显著短于对照组（P<0.05）。治疗前2组患儿血清CK、LDH、AST、α-HBD、CK-MB水平比较差异无统计学意义（P>0.05）；2组患儿治疗后血清CK、LDH、AST、α-HBD、CK-MB水平显著低于治疗前（P<0.05）；治疗后，观察组患儿血清CK、LDH、AST、α-HBD、CK-MB水平显著低于对照组（P<0.05）。治疗前2组患儿粪便中肠球菌、大肠埃希菌、双歧杆菌和乳酸杆菌的菌落数比较差异无统计学意义（P>0.05）；2组患儿治疗后粪便中肠球菌、大肠埃希菌的菌落数显著少于治疗前，双歧杆菌和乳酸杆菌的菌落数显著多于治疗前（P<0.05）；治疗后，观察组患儿粪便中肠球菌、大肠埃希菌的菌落数显著少于对照组，双歧杆菌和乳酸杆菌的菌落数显著多于对照组（P<0.05）。治疗前2组患儿血清DAO和Fcp水平比较差异无统计学意义（P>0.05）；治疗后2组患儿血清DAO和Fcp水平显著低于治疗前（P<0.05）；治疗后，观察组患儿血清DAO和Fcp水平显著低于对照组（P<0.05）。观察组和对照组患儿治疗总有效率分别为95.45%（42/44）、79.55%（35/44）；观察组患儿治疗总有效率显著高于对照组（χ2=5.091，P<0.05）。观察组和对照组患儿不良反应发生率分别为6.82%（3/44）、2.27%（1/44），2组患儿不良反应发生率比较差异无统计学意义（χ2=0.262，P>0.05）。结论　重组人干扰素α-1b和沙棘干乳剂联合治疗可有效改善病毒性腹泻患儿的临床症状、肠道菌群，减轻肠黏膜损伤和心肌损害。
Abstract:
Objective　To investigate the effect of recombinant human interferon α-1b combined with Shaji Ganruji in the treatment of children with viral diarrhea.Methods　A total of 88 children with viral diarrhea treated in the Second Affiliated Hospital of Luohe Medical College from March 2017 to February 2019 were selected as the research subjects,and the patients were divided into observation group and control group according to the treatment methods,with 44 cases in each group.All patients were given routine treatment measures such as correcting acidosis,intravenous rehydration to correct dehydration,lactose free diet,smectite powder and Bifidobacterium tetrad viable tablets.The patients in the observation group were treated with recombinant human interferon α-1b and Shaji Ganruji on the basis of routine treatment.The dehydration correction time,diarrhea offtime,hospitalization time and adverse reactions were observed and compared between the two groups.The levels of serum creatine kinase (CK),lactate dehydrogenase (LDH),aspartate aminotransferase (AST),α-hydroxybutyrate dehydrogenase(α-HBD),creatine kinase MB(CK-MB),diamine oxidase (DAO) and fecal calprotectin (Fcp),intestinal flora were compared.The clinical efficacy of patients in the two groups was determined after treatment.Results　The dehydration correction time,diarrhea offtime and hospitalization time in the observation group were significantly shorter than those in the control group (P<0.05).There was no significant difference in the levels of serum CK,LDH,AST,α-HBD and CK-MB between the two groups before treatment (P>0.05).The levels of serum CK,LDH,AST,α-HBD and CK-MB after treatment were significantly lower than those before treatment in the two groups (P<0.05).The levels of serum CK,LDH,AST,α-HBD and CK-MB in the observation group were significantly lower than those in the control group after treatment (P<0.05).There was no significant difference in the colony numbers of Enterococcus,Escherichia coli,Bifidobacterium and Lactobacillus in faeces of patients between the two groups before treatment (P>0.05).The colony numbers of Enterococcus and Escherichia coli in faeces after treatment were significantly less than those before treatment,and the colony numbers of Bifidobacterium and Lactobacillus in faeces were significantly more than those before treatment (P<0.05).After treatment,the colony numbers of Enterococcus and Escherichia coli in faeces of patients in the observation group were significantly less than those in the control group,and the colony numbers of Bifidobacterium and Lactobacillus were significantly more than those in the control group (P<0.05).There was no significant difference in the levels of serum DAO and Fcp between the two groups before treatment (P>0.05).The levels of serum DAO and Fcp after treatment were significantly lower than those before treatment in the two groups (P<0.05).The levels of serum DAO and Fcp in the observation group were significantly lower than those in the control group after treatment (P<0.05).The total effective rate of patients in the observation group and the control group was 95.45% (42/44) and 79.55% (35/44),respectivelythe total effective rate of patients in the observation group was significantly higher than that in the control group(χ2=5.091,P<0.05).The incidence of adverse reactions of patients in the observation group and the control group was 6.82% (3/44) and 2.27% (1/44),respectivelythere was no significant difference in the incidence of adverse reactions of patients between the two groups(χ2=0.262,P>0.05).Conclusion　Recombinant human interferon α-1b combined with Shaji Ganruji can effectively improve the clinical symptoms and intestinal flora of children with viral diarrhea,and reduce intestinal mucosal injury and myocardial damage.

参考文献/References:

［1］　MEIER J L.Viral acute gastroenteritis in special populations［J］.Gastroenterol Clin North Am,2021,50(2):305-322.
［2］　CHEN C,WANG L P,YU J X,et al.Prevalence of enteropathogens in outpatients with acute diarrhea from urban and rural areas,southeast china,2010-2014［J］.Am J Trop Med Hyg,2019,101(2):310-318.
［3］　CHEN L N,SHI M F,DENG Q M,et al.A multi-center randomized prospective study on the treatment of infant bronchiolitis with interferon α1b nebulization［J］.PLoS One,2020,15(2):e0228391.
［4］　中华医学会儿科学分会消化学组，《中华儿科杂志》编辑委员会.中国儿童急性感染性腹泻病临床实践指南［J］.中华儿科杂志，2016，54（7）：483-488.
THE SUBSPECIALTY GROUP OF GASTROENTEROLOGY,THE SOCIETY OF PEDIATRICS,CHINESE MEDICAL ASSOCIATION,THE EDITORIAL BOARD，CHINESE JOURNAL OF PEDIATRICS.Practice guideline for acute infectious diarrhea in Chinese children［J］.Chin J Pediatr，2016,54(7):483-488.
［5］　骆葵丽.微生物制剂+葡萄糖酸锌对小儿轮状病毒性腹泻的疗效探讨［J］.中国医药科学，2018，8（20）：77-79.
LUO K L.Exploration on curative effect of microbial preparationcombined with zinc gluconate in treatment of children with rotavirus diarrhea［J］.Chin Med Pharm,2018,8(20):77-79.
［6］　GHOSH S,MALIK Y S,KOBAYASHI N.Therapeutics and immunoprophylaxis against noroviruses and rotaviruses［J］.Curr Drug Metab,2018,19(3):170-191.
［7］　CHEN J,LI Y,LAI F,et al.Functional comparison of interferon-α subtypes reveals potent hepatitis B virus suppression by a concerted action of interferon-α and interferon-γ signaling［J］.Hepatology,2021,73(2):486-502.
［8］　HUANG H I,LIN J Y,CHEN S H.EV71 infection induces IFNβ expression in neural cells［J］.Viruses,2019,11(12):1121.
［9］　潘家华，羊礼荣，韩旻，等.口服重组人干扰素α-2b治疗小儿轮状病毒肠炎的多中心随机双盲对照研究［J］.儿科药学杂志，2019，25（1）：5-11.
PAN J H,YANG L R,HAN M,et al.A multicenter,randomized,double-blind and placebo-controlled clinical trial of oral recombinant human interferon α-2b on children with rotavirus enteritis［J］.J Pediatr Pharm,2019,25(1):5-11.
［10］　商亚敏，李英，王文英，等.赛若金联合无乳糖饮食对小儿轮状病毒感染性肠炎肠黏膜损伤及心肌酶谱的影响［J］.中华医院感染学杂志，2017，27（18）：4224-4227.
SHANG Y M,LI Y,WANG W Y,et al.Effect of sinogen combined with lactose-freee diet on rotavirus infectious entrritis intestinal mucosal lesions and myocardial enzymmes of children［J］.Chin J Nosocomiol,2017,27(18):4224-4227.
［11］　LI Z L,HUAN C,WANG H,et al.TRIM21-mediated proteasomal degradation of SAMHD1 regulates its antiviral activity［J］.EMBO Rep,2020,21(1):e47528.
［12］　刘跃平，石涵，李红，等.益生菌对病毒性腹泻患者菌群结构及黏膜屏障功能变化的影响［J］.中国预防医学杂志，2018，19（6）：448-451.
LIU Y P,SHI H,LI H,et al.Effect of probiotics on gut microbiota and the functional change of mucosal barrier in patients with viral diarrhea［J］.Chin Prev Med,2018,19(6):448-451.
［13］　NEREE A T,SORET R,MARCOCCI L,et al.Vegetal diamine oxidase alleviates histamine-induced contraction of colonic muscles［J］.Sci Rep,2020,10(1):21563.
［14］　RICCIUTO A,GRIFFITHS A M.Clinical value of fecal calprotectin［J］.Crit Rev Clin Lab Sci,2019,56(5):307-320.
［15］　CISAR F,PIZZOL A,RIGAZIO C,et al.Fecal calprotectin in the pediatric population:a 2020 update［J］.Minerva Pediatr,2020,72(6):514-522.
［16］　罗世杰，金瑄，郭亚雄，等.沙棘干乳剂治疗儿童食积型功能性便秘临床研究［J］.现代中医药，2020，40（4）：99-101.
LUO S J,JIN X,GUO Y X,et al.Clinical study on seabuckthorn dry emulsion in the treatment of functional constipation in children with food accumulation［J］.Modern Tradit Chin Med,2020，40（4）：99-101.
［17］　陈虹余，李正琳.小儿推拿疗法联合沙棘干乳剂治疗儿童急性肠系膜淋巴结炎23例［J］.河南中医，2020，40（8）：1285-1288.
CHEN H Y,LI Z l.Twenty-three cases of children acute mesenteric lymphadenitis treated with children massage therapy in combination with seabuckthorn dry emulsion［J］.Henan Tradit Chin Med,2020,40(8):1285-1288.
［18］　GULERSOY E,OK M,YILDIZ R,et al.Assessment of intestinal and cardiac-related biomarkers in dogs with parvoviral enteritis［J］.Pol J Vet Sci,2020,23(2):211-219.
［19］　董建华.病毒性腹泻患儿血清CK、CK-MB与酸中毒的相关性研究［J］.检验医学与临床，2019，16（19）：2868-2871.
DONG J H.Correlation between serum CK,CK-MB and acidosis in children with viral diarrhea［J］.Lab Med Clin,2019,16(19):2868-2871.
［20］　张玉凤，万涵，符佳，等.CK-MB、cTnI及BNP检测对小儿轮状病毒性肠炎心肌损害的临床意义［J］.中国临床医生杂志，2018，46（10）：105-107.
ZHANG Y F,WAN H,FU J.Clinical significance of CK-MB,cTnI and BNP in myocardial damage of children with rotavirus enteritis［J］.Chin J Clin,2018,46(10):105-107.

更新日期/Last Update: 2022-01-05